IRCT20220211053992N24招募中Unknown
In vivo fasted-state bioequivalence study of Baricitinib tablets manufactured by Sobhan oncology Pharmaceutical Co. compared to innovator product
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 59 years（—）
- 性别
- Male
入选标准
- •General Health (in terms of Liver, Heart and Kidney diseases)
- •Age between 18 to 59 years
排除标准
- •History of cardiovascular, liver, and kidney disease
- •Alcohol and drug addiction
- •History of drug allergy
研究者
相似试验
招募中
Unknown
Bioequivalence study of Bromhexine mg tabletIn the present study, the products will be administered to healthy volunteers.IRCT20210519051345N48Tabriz University of Medical Sciences24
招募中
Unknown
Investigating bioequivalence of Voriconazole tabletIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N30Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Primidone suspensioIn the present study, the products will be administered to healthy volunteers..IRCT20220211053992N17Tabriz University of Medical Sciences24
招募中
Unknown
In vivo Bioequivalence study of Evererolimus tabletsIRCT20220211053992N31Tabriz University of Medical Sciences24
尚未招募
Unknown
In vivo Bioequivalence study of Famotidine tabletIRCT20220211053992N35Tabriz University of Medical Sciences24